Mark Morrow
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 7
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 4
- Lung Cancer Research Studies 2
- Cancer-related Molecular Pathways 2
- Peptidase Inhibition and Analysis 2
-
- Angiogenesis and VEGF in Cancer 4
- Co-authors
- S. Gail Eckhardt (6 shared papers)Daniel L. Gustafson (5 shared papers)Todd M. Pitts (3 shared papers)Lia Gore (6 shared papers)M. Basche (4 shared papers)Scott N. Holden (3 shared papers)Sabine Eckhardt (5 shared papers)S. Gail Eckhardt (3 shared papers)
- Journals
- Clinical Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)Molecular Cancer Therapeutics (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Mark Morrow
18 papers receiving 649 citations
Peers
Comparison fields: 5 of 64
- Oncology 312
- Immunology and Allergy 62
- Cancer Research 151
- Cell Biology 144
- Molecular Biology 392
Countries citing papers authored by Mark Morrow
This map shows the geographic impact of Mark Morrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Morrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Morrow more than expected).
Fields of papers citing papers by Mark Morrow
This network shows the impact of papers produced by Mark Morrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Morrow. The network helps show where Mark Morrow may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Morrow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 102 | |
| 2 | 2007 | 97 | |
| 3 | 2006 | 77 | |
| 4 | 2000 | 72 | |
| 5 | 2009 | 59 | |
| 6 | 2010 | 57 | |
| 7 | 2006 | 36 | |
| 8 | 2007 | 33 | |
| 9 | 2007 | 30 | |
| 10 | 2007 | 22 | |
| 11 | 2008 | 19 | |
| 12 | Carcinoembryonic antigen in patients with squamous cell carcinoma of the cervix uteri and vulva. | 1974 | 14 |
| 13 | 2006 | 13 | |
| 14 | Verapamil enhances antitumor activity without increasing myeloid toxicity. | 1987 | 10 |
| 15 | 2008 | 7 | |
| 16 | 2005 | 7 | |
| 17 | 2013 | 3 | |
| 18 | 2006 | 3 |
About Mark Morrow
Mark Morrow is a scholar working on Oncology, Molecular Biology, Cell Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 18 papers that have together received 661 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (5 papers), HER2/EGFR in Cancer Research (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Proteoglycans and glycosaminoglycans research (2 papers), Lung Cancer Research Studies (2 papers), Cancer-related Molecular Pathways (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Oncology (312 citations), Immunology and Allergy (62 citations), Cancer Research (151 citations), Cell Biology (144 citations) and Molecular Biology (392 citations). Mark Morrow has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include S. Gail Eckhardt, Daniel L. Gustafson, Todd M. Pitts, Lia Gore, M. Basche, Scott N. Holden, Sabine Eckhardt, S. Gail Eckhardt, John J. Tentler and Teresa Troiani. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Molecular Cancer Therapeutics, Cancer Chemotherapy and Pharmacology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.